Chen Yuan1, Ana Babic1, Natalia Khalaf2,3, Jonathan A Nowak4,5, Lauren K Brais1, Douglas A Rubinson1, Kimmie Ng1, Andrew J Aguirre1, Pari V Pandharipande6, Charles S Fuchs7, Edward L Giovannucci8,9,10, Meir J Stampfer8,9,10, Michael H Rosenthal1, Chris Sander11,12, Peter Kraft8,13, Brian M Wolpin1. 1. Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. 2. Department of Internal Medicine, Baylor College of Medicine, Houston, Texas. 3. Gastroenterology and Hepatology, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas. 4. Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. 5. Department of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. 6. Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. 7. Yale Cancer Center, Smilow Cancer Hospital, New Haven, Connecticut. 8. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 9. Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 10. Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. 11. Department of Cell Biology, Harvard Medical School, Boston, Massachusetts. 12. cBio Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. 13. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Abstract
Importance: Pancreatic cancer is the third-leading cause of cancer death in the United States; however, few high-risk groups have been identified to facilitate early diagnosis strategies. Objective: To evaluate the association of diabetes duration and recent weight change with subsequent risk of pancreatic cancer in the general population. Design, Setting, and Participants: This cohort study obtained data from female participants in the Nurses' Health Study and male participants in the Health Professionals Follow-Up Study, with repeated exposure assessments over 30 years. Incident cases of pancreatic cancer were identified from self-report or during follow-up of participant deaths. Deaths were ascertained through reports from the next of kin, the US Postal Service, or the National Death Index. Data collection was conducted from October 1, 2018, to December 31, 2018. Data analysis was performed from January 1, 2019, to June 30, 2019. Exposures: Duration of physician-diagnosed diabetes and recent weight change. Main Outcome and Measures: Hazard ratios (HRs) for subsequent development of pancreatic cancer. Results: Of the 112 818 women (with a mean [SD] age of 59.4 [11.7] years) and 46 207 men (with a mean [SD] age of 64.7 [10.8] years) included in the analysis, 1116 incident cases of pancreatic cancers were identified. Compared with participants with no diabetes, those with recent-onset diabetes had an age-adjusted HR for pancreatic cancer of 2.97 (95% CI, 2.31-3.82) and those with long-standing diabetes had an age-adjusted HR of 2.16 (95% CI, 1.78-2.60). Compared with those with no weight loss, participants who reported a 1- to 4-lb weight loss had an age-adjusted HR for pancreatic cancer of 1.25 (95% CI, 1.03-1.52), those with a 5- to 8-lb weight loss had an age-adjusted HR of 1.33 (95% CI, 1.06-1.66), and those with more than an 8-lb weight loss had an age-adjusted HR of 1.92 (95% CI, 1.58-2.32). Participants with recent-onset diabetes accompanied by weight loss of 1 to 8 lb (91 incident cases per 100 000 person-years [95% CI, 55-151]; HR, 3.61 [95% CI, 2.14-6.10]) or more than 8 lb (164 incident cases per 100 000 person-years [95% CI, 114-238]; HR, 6.75 [95% CI, 4.55-10.00]) had a substantially increased risk for pancreatic cancer compared with those with neither exposure (16 incident cases per 100 000 person-years; 95% CI, 14-17). Incidence rates were even higher among participants with recent-onset diabetes and weight loss with a body mass index of less than 25 before weight loss (400 incident cases per 100 000 person-years) or whose weight loss was not intentional judging from increased physical activity or healthier dietary choices (334 incident cases per 100 000 person-years). Conclusions and Relevance: This study demonstrates that recent-onset diabetes accompanied by weight loss is associated with a substantially increased risk for developing pancreatic cancer. Older age, previous healthy weight, and no intentional weight loss further elevate this risk.
Importance: Pancreatic cancer is the third-leading cause of cancer death in the United States; however, few high-risk groups have been identified to facilitate early diagnosis strategies. Objective: To evaluate the association of diabetes duration and recent weight change with subsequent risk of pancreatic cancer in the general population. Design, Setting, and Participants: This cohort study obtained data from female participants in the Nurses' Health Study and male participants in the Health Professionals Follow-Up Study, with repeated exposure assessments over 30 years. Incident cases of pancreatic cancer were identified from self-report or during follow-up of participantdeaths. Deaths were ascertained through reports from the next of kin, the US Postal Service, or the National Death Index. Data collection was conducted from October 1, 2018, to December 31, 2018. Data analysis was performed from January 1, 2019, to June 30, 2019. Exposures: Duration of physician-diagnosed diabetes and recent weight change. Main Outcome and Measures: Hazard ratios (HRs) for subsequent development of pancreatic cancer. Results: Of the 112 818 women (with a mean [SD] age of 59.4 [11.7] years) and 46 207 men (with a mean [SD] age of 64.7 [10.8] years) included in the analysis, 1116 incident cases of pancreatic cancers were identified. Compared with participants with no diabetes, those with recent-onset diabetes had an age-adjusted HR for pancreatic cancer of 2.97 (95% CI, 2.31-3.82) and those with long-standing diabetes had an age-adjusted HR of 2.16 (95% CI, 1.78-2.60). Compared with those with no weight loss, participants who reported a 1- to 4-lb weight loss had an age-adjusted HR for pancreatic cancer of 1.25 (95% CI, 1.03-1.52), those with a 5- to 8-lb weight loss had an age-adjusted HR of 1.33 (95% CI, 1.06-1.66), and those with more than an 8-lb weight loss had an age-adjusted HR of 1.92 (95% CI, 1.58-2.32). Participants with recent-onset diabetes accompanied by weight loss of 1 to 8 lb (91 incident cases per 100 000 person-years [95% CI, 55-151]; HR, 3.61 [95% CI, 2.14-6.10]) or more than 8 lb (164 incident cases per 100 000 person-years [95% CI, 114-238]; HR, 6.75 [95% CI, 4.55-10.00]) had a substantially increased risk for pancreatic cancer compared with those with neither exposure (16 incident cases per 100 000 person-years; 95% CI, 14-17). Incidence rates were even higher among participants with recent-onset diabetes and weight loss with a body mass index of less than 25 before weight loss (400 incident cases per 100 000 person-years) or whose weight loss was not intentional judging from increased physical activity or healthier dietary choices (334 incident cases per 100 000 person-years). Conclusions and Relevance: This study demonstrates that recent-onset diabetes accompanied by weight loss is associated with a substantially increased risk for developing pancreatic cancer. Older age, previous healthy weight, and no intentional weight loss further elevate this risk.
Authors: Ben Boursi; Brian Finkelman; Bruce J Giantonio; Kevin Haynes; Anil K Rustgi; Andrew D Rhim; Ronac Mamtani; Yu-Xiao Yang Journal: Gastroenterology Date: 2016-12-05 Impact factor: 22.682
Authors: Suresh T Chari; Cynthia L Leibson; Kari G Rabe; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen Journal: Gastroenterology Date: 2005-08 Impact factor: 22.682
Authors: Anirban Maitra; Ayush Sharma; Randall E Brand; Stephen K Van Den Eeden; William E Fisher; Phil A Hart; Steven J Hughes; Kieren J Mather; Stephen J Pandol; Walter G Park; Ziding Feng; Jose Serrano; Jo Ann S Rinaudo; Sudhir Srivastava; Suresh T Chari Journal: Pancreas Date: 2018 Nov/Dec Impact factor: 3.327
Authors: Rahul Pannala; Cynthia L Leibson; Kari G Rabe; Lawrence J Timmons; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen; Suresh T Chari Journal: Am J Gastroenterol Date: 2009-06-09 Impact factor: 10.864
Authors: Jonathan J Hue; Kavin Sugumar; Ravi K Kyasaram; John Shanahan; Joshua Lyons; Lee M Ocuin; Luke D Rothermel; Jeffrey M Hardacre; John B Ammori; Goutham Rao; Jordan M Winter; Sarah C Markt Journal: Ann Surg Oncol Date: 2021-04-09 Impact factor: 5.344
Authors: C Yuan; J Kim; Q L Wang; A A Lee; A Babic; L T Amundadottir; A P Klein; D Li; M L McCullough; G M Petersen; H A Risch; R Z Stolzenberg-Solomon; K Perez; K Ng; E L Giovannucci; M J Stampfer; P Kraft; B M Wolpin Journal: Ann Oncol Date: 2022-04-06 Impact factor: 51.769
Authors: Qi Jin; Phil A Hart; Ni Shi; Joshua J Joseph; Macarius Donneyong; Darwin L Conwell; Steven K Clinton; Zobeida Cruz-Monserrate; Theodore M Brasky; Lesley F Tinker; Simin Liu; Aladdin H Shadyab; Cynthia A Thomson; Lihong Qi; Thomas Rohan; Fred K Tabung Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-04-07 Impact factor: 4.254
Authors: Jonathan J Hue; Lee M Ocuin; Ravi K Kyasaram; John Shanahan; Goutham Rao; Luke D Rothermel; John B Ammori; Jeffrey M Hardacre; Jordan M Winter; Sarah C Markt Journal: Ann Surg Oncol Date: 2022-01-23 Impact factor: 5.344